Personal profile
Fingerprint
Dive into the research topics where Se Hoon Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational study
Jung, H. A., Merkin, R., Feng, A. L., Lee, D., Lee, K., Park, S., Sun, J. M., Lee, S. H., Ahn, J. S., Ahn, M. J., Wirth, L. J. & Park, J. C., Feb 2026, In: ESMO Open. 11, 2, 106046.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project
Rizzo, A., Myint, Z. W., Ciccimarra, F., Zgura, A., Matrana, M. R., Büttner, T., Kopecky, J., Vida, A. R., Rizzo, M., Fujita, K., Brunetti, O., Santini, D., Park, S. H., Formisano, L., Poprach, A., Kucharz, J., Comes, M. C., Bove, S., Fanizzi, A. & Massafra, R. & 6 others, , Dec 2026, In: Clinical and Experimental Medicine. 26, 1, 75.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Effect of First-Line Combination Systemic Therapy on Favorable-Risk Clear Cell Renal Cell Carcinoma: A Retrospective Study
Lee, S. I., Kwon, M., Lim, S. H. & Park, S. H., Jan 2026, In: Biomedicines. 14, 1, 238.Research output: Contribution to journal › Article › peer-review
Open Access -
Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma
Kikuchi, E., Van der Heijden, M. S., Valderrama, B. P., Gupta, S., Bedke, J., Shin, S. J., Li, J. R., Guo, J., Danchaivijitr, P., Kanesvaran, R., Park, S. H., Su, W. P., Kandori, S., Bae, W. K., Wong, A., Gorla, S., Bavle, A., Yu, X., Lu, Y. T. & Powles, T., Mar 2026, In: International Journal of Clinical Oncology. 31, 3, p. 436-446 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)
Molina-Cerrillo, J., Roviello, G., Bourlon, M. T., Studentova, H., Fiala, O., Cerbone, L., Kucharz, J., Ansari, J., Zeppellini, A., Taha, T., Buti, S., Ürün, Y., Scagliarini, S., Li, H., Sunela, K., Park, S. H., Rizzo, M., Zgura, A., Chiari, R. & Seront, E. & 10 others, , 1 Mar 2026, In: International Journal of Cancer. 158, 5, p. 1396-1405 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations